Corey McCann

Insider Reports History

Location
Boston, MA
Signature
/s/ Stacie S. Aarestad, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Corey McCann:

Company Role Class Num Shares Value Price $ Report Date Ownership
Pear Therapeutics, Inc. President and CEO, Director Restricted Stock Units 2,857,142 15 Feb 2023 Direct

Insider Reports Filed by Corey McCann

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000106299323004039-mccann-corey-2023-02-15 Pear Therapeutics, Inc. 15 Feb 2023 1 $0 4 President and CEO, Director 17 Feb 2023, 15:12
/report/000106299323001323-mccann-corey-2023-01-20 Pear Therapeutics, Inc. 20 Jan 2023 1 -$39,246 4 President and CEO, Director 24 Jan 2023, 15:06
/report/000106299323001039-mccann-corey-2023-01-14 Pear Therapeutics, Inc. 14 Jan 2023 2 $0 4 President and CEO, Director 18 Jan 2023, 16:03
/report/000106299322004977-mccann-corey-2022-02-16 Pear Therapeutics, Inc. 16 Feb 2022 2 $0 4 President and CEO, Director 18 Feb 2022, 15:40
/report/000106299321012388-mccann-corey-2021-12-03 Pear Therapeutics, Inc. 03 Dec 2021 3 $0 4 President and CEO, Director 07 Dec 2021, 16:23
/report/000106299321012355-mccann-corey-2021-12-03 Pear Therapeutics, Inc. 03 Dec 2021 0 $0 3 President and CEO, Director 07 Dec 2021, 16:06